In vitro investigations revealed cetuximab-conjugated TPGS micelles exhibited remarkably higher cellular uptake as compared to unconjugated NPs on MDA-MB-468 and MDA-MB-231 breast cancer cells which overexpressed EGFR on the cell surface. Here, EGFR is linked to breast carcinoma.